Tuesday, December 25, 2012

• Investments In Novel IL-12 Adminstration Platforms In The Fight Against Cancerat Seeking Alpha (Tue, Dec 25)

Thursday, December 13, 2012

• 1 Catalyst Biotech Investors Need to Watchat Motley Fool (Thu, Dec 13)
• Mid-Week Biopharma Catalyst Trades To Considerat Seeking Alpha (Thu, Dec 13)

Wednesday, December 12, 2012

• Ziopharm shares fall on analyst downgradeAP (Wed, Dec 12)

Monday, December 10, 2012

• Ziopharm: Key Oncology Catalyst Approachingat Seeking Alpha (Mon, Dec 10)

Thursday, December 6, 2012

• Upcoming Catalysts For 4 Biotech Stocksat Seeking Alpha (Thu, Dec 6)

Monday, November 26, 2012

• FDA on Pace to Approve More New Drugs in 2012 Than the 30 Approved in 2011Marketwired (Mon, Nov 26)

Thursday, November 8, 2012

• ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Unregistered Sale of Equity Securities, Other Events, Financial StatementsEDGAR Online (Thu, Nov 8)
• ZIOPHARM ONCOLOGY INC Files SEC form 10-Q, Quarterly ReportEDGAR Online (Thu, Nov 8)

Friday, October 26, 2012

• Richard Pearson Responds On Ziopharmat Seeking Alpha (Fri, Oct 26)

Thursday, October 25, 2012

• 5 Stocks Under $10 Set to Soarat TheStreet (Thu, Oct 25)
• Ziopharm announces clinical activity in Phase 1 study of Ad-RTS IL-12at theflyonthewall.com (Thu, Oct 25)

Wednesday, October 24, 2012

• Smaller, Faster Clinical Trials Considered by the FDA for Developers of Critical Drugs and TreatmentsMarketwired (Wed, Oct 24)

Tuesday, October 23, 2012

• The Bears Weigh In On Ziopharmat Seeking Alpha (Tue, Oct 23)
• Biotech Stock Mailbag: Ziopharm, Sarepta, Vivus, Aegerion, Gileadat TheStreet (Tue, Oct 23)

Monday, October 22, 2012

• Ziopharm Reiterated at Outperform with $10 Target and 4 Stock Analyses Making Headlinesat Wall St. Cheat Sheet (Mon, Oct 22)
• Why These Stocks Are Soaring Higherat Motley Fool (Mon, Oct 22)
• Ziopharm: Options Trade for Phase III Dataat TheStreet (Mon, Oct 22)

Friday, October 19, 2012

• ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Fri, Oct 19)
• Ziopharm's responseat Forbes (Fri, Oct 19)
• Ziopharm's Responseat Forbes (Fri, Oct 19)
• Ziopharm's responseat Forbes (Fri, Oct 19)

Thursday, October 18, 2012

• ZIOP: Undisclosed FDA warning letter and Palifosfamide instability are just the beginningat Forbes (Thu, Oct 18)

Friday, October 5, 2012

• Ziopharm bulls look for explosive moveoptionMONSTER (Fri, Oct 5)

Friday, September 7, 2012

• ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Fri, Sep 7)

Add ZIOP News to My Yahoo!